Matthew Suffness

1.9k total citations
27 papers, 1.3k citations indexed

About

Matthew Suffness is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Matthew Suffness has authored 27 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Oncology and 5 papers in Organic Chemistry. Recurrent topics in Matthew Suffness's work include Cancer Treatment and Pharmacology (5 papers), Cancer therapeutics and mechanisms (4 papers) and Phytochemistry and Bioactive Compounds (3 papers). Matthew Suffness is often cited by papers focused on Cancer Treatment and Pharmacology (5 papers), Cancer therapeutics and mechanisms (4 papers) and Phytochemistry and Bioactive Compounds (3 papers). Matthew Suffness collaborates with scholars based in United States, Malaysia and India. Matthew Suffness's co-authors include John Douros, Gordon M. Cragg, Saul A. Schepartz, Michael R. Grever, Kenneth M. Snader, David Newman, Arnold Brossi, S. Morris Kupchan, Brian Leyland‐Jones and Jacqueline Plowman and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Medicinal Chemistry and The Journal of Organic Chemistry.

In The Last Decade

Matthew Suffness

26 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matthew Suffness United States 17 704 291 282 248 200 27 1.3k
William A. Court Canada 12 694 1.0× 206 0.7× 156 0.6× 228 0.9× 119 0.6× 26 1.3k
SADAFUMI OMURA Japan 18 681 1.0× 300 1.0× 261 0.9× 158 0.6× 76 0.4× 51 1.1k
TAKEO YOSHIOKA Japan 18 487 0.7× 358 1.2× 300 1.1× 185 0.7× 133 0.7× 61 1.0k
M Suffness United States 15 590 0.8× 201 0.7× 116 0.4× 352 1.4× 330 1.6× 19 1.4k
Yusuf J. Abul‐Hajj United States 24 805 1.1× 231 0.8× 150 0.5× 252 1.0× 143 0.7× 81 1.8k
Thomas G. McCloud United States 22 577 0.8× 233 0.8× 216 0.8× 213 0.9× 108 0.5× 38 1.2k
Ruth I. Geran United States 9 624 0.9× 225 0.8× 126 0.4× 153 0.6× 318 1.6× 12 1.3k
Nathaniel H. Greenberg United States 6 536 0.8× 191 0.7× 120 0.4× 158 0.6× 261 1.3× 9 1.1k
Eric Débiton France 25 855 1.2× 555 1.9× 213 0.8× 201 0.8× 157 0.8× 51 1.9k
Gerhard Erkel Germany 21 514 0.7× 289 1.0× 442 1.6× 125 0.5× 186 0.9× 66 1.2k

Countries citing papers authored by Matthew Suffness

Since Specialization
Citations

This map shows the geographic impact of Matthew Suffness's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Suffness with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Suffness more than expected).

Fields of papers citing papers by Matthew Suffness

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew Suffness. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Suffness. The network helps show where Matthew Suffness may publish in the future.

Co-authorship network of co-authors of Matthew Suffness

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew Suffness. A scholar is included among the top collaborators of Matthew Suffness based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew Suffness. Matthew Suffness is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Suffness, Matthew. (2021). TAXOL®. 2 indexed citations
2.
Cragg, Gordon M., Saul A. Schepartz, Matthew Suffness, & Michael R. Grever. (1993). The Taxol Supply Crisis. New NCI Policies for Handling the Large-Scale Production of Novel Natural Product Anticancer and Anti-HIV Agents. Journal of Natural Products. 56(10). 1657–1668. 210 indexed citations
3.
Powell, Richard G., Ronald D. Plattner, & Matthew Suffness. (1990). Occurrence of Sesbanimide in Seeds of ToxicSesbaniaSpecies. Weed Science. 38(2). 148–152. 16 indexed citations
4.
Brossi, Arnold, Herman J. C. Yeh, Maria Chrzanowska, et al.. (1988). Colchicine and its analogues: Recent findings. Medicinal Research Reviews. 8(1). 77–94. 136 indexed citations
5.
Cragg, Gordon M. & Matthew Suffness. (1988). Metabolism of plant-derived anticancer agents. Pharmacology & Therapeutics. 37(3). 425–461. 40 indexed citations
6.
Brossi, Arnold, et al.. (1987). A novel synthesis of colchicide and analogs from thiocolchicine and congeners: reevaluation of colchicide as a potential antitumor agent. Journal of Medicinal Chemistry. 30(4). 732–735. 27 indexed citations
7.
Hoth, Daniel F., Matthew Suffness, Jacqueline Plowman, et al.. (1986). Didemnin B. Investigational New Drugs. 4(3). 279–284. 71 indexed citations
8.
Spjut, Richard W., Matthew Suffness, Gordon M. Cragg, & Daniel H. Norris. (1986). Mosses, Liverworts, and Hornworts Screened for Antitumor Agents. Economic Botany. 40(3). 23 indexed citations
9.
Foster, Brenda J., K Clagett-Carr, Dale Shoemaker, et al.. (1985). Echinomycin: The first bifunctional intercalating agent in clinical trials. Investigational New Drugs. 3(4). 403–410. 53 indexed citations
10.
Pettit, George R., Gordon M. Cragg, Matthew Suffness, et al.. (1984). Antineoplastic agents. 104. Isolation and structure of the Phyllanthus acuminatus Vahl (Euphorbiaceae) glycosides. The Journal of Organic Chemistry. 49(22). 4258–4266. 36 indexed citations
11.
Suffness, Matthew & John Douros. (1982). Current Status of the NCI Plant and Animal Product Program. Journal of Natural Products. 45(1). 1–14. 189 indexed citations
12.
Suffness, Matthew & John Douros. (1981). Discovery of antitumor agents from natural sources. Trends in Pharmacological Sciences. 2. 307–310. 6 indexed citations
13.
Douros, John & Matthew Suffness. (1981). New antitumor substances of natural origin. Cancer Treatment Reviews. 8(1). 63–87. 150 indexed citations
14.
Douros, John & Matthew Suffness. (1978). New natural products of interest under development at the National Cancer Institute. Cancer Chemotherapy and Pharmacology. 1(2). 91–100. 31 indexed citations
15.
Suffness, Matthew, et al.. (1974). Potential DRUG Interactions and Adverse Effects Related to Aspirin. Drug Intelligence & Clinical Pharmacy. 8(12). 694–699. 4 indexed citations
16.
Kupchan, S. Morris, Matthew Suffness, & Eric M. Gordon. (1970). Isolation and structure elucidation of oxoxylopine, a new oxoaporphine alkaloid from Stephania abyssinica. The Journal of Organic Chemistry. 35(5). 1682–1684. 15 indexed citations
17.
Kupchan, S. Morris & Matthew Suffness. (1970). The structure of stephisoferuline, a new hasubanan ester alkaloid from. Tetrahedron Letters. 11(57). 4975–4978. 6 indexed citations
18.
Kupchan, S. Morris, Matthew Suffness, Richard J. McClure, & G. A. Sim. (1970). Structure of stephavanine, a novel Hasubanan ester alkaloid. Journal of the American Chemical Society. 92(19). 5756–5758. 5 indexed citations
19.
Tamelen, Eugene E. Van, et al.. (1970). Biogenetic-type synthesis of the isoeuphenol system. Journal of the American Chemical Society. 92(24). 7202–7204. 14 indexed citations
20.
Kupchan, S. Morris, Matthew Suffness, David White, Andrew T. McPhail, & G. A. Sim. (1968). Isolation and structural elucidation of 4-demethylhasubanonine, a new alkaloid from Stephania hernandifolia. The Journal of Organic Chemistry. 33(12). 4529–4532. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by William A. Court Breakdown of academic impact, for papers by SADAFUMI OMURA Breakdown of academic impact, for papers by TAKEO YOSHIOKA Breakdown of academic impact, for papers by M Suffness Breakdown of academic impact, for papers by Yusuf J. Abul‐Hajj Breakdown of academic impact, for papers by Thomas G. McCloud Breakdown of academic impact, for papers by Ruth I. Geran Breakdown of academic impact, for papers by Nathaniel H. Greenberg Breakdown of academic impact, for papers by Eric Débiton Breakdown of academic impact, for papers by Gerhard Erkel
Rankless by CCL
2026